IMCC
Price
$2.66
Change
-$0.00 (-0.00%)
Updated
Aug 15 closing price
Capitalization
16.21M
SCYX
Price
$0.84
Change
+$0.04 (+5.00%)
Updated
Aug 15 closing price
Capitalization
32.77M
79 days until earnings call
Interact to see
Advertisement

IMCC vs SCYX

Header iconIMCC vs SCYX Comparison
Open Charts IMCC vs SCYXBanner chart's image
IM Cannabis
Price$2.66
Change-$0.00 (-0.00%)
Volume$17.52K
Capitalization16.21M
SCYNEXIS
Price$0.84
Change+$0.04 (+5.00%)
Volume$106.24K
Capitalization32.77M
IMCC vs SCYX Comparison Chart in %
Loading...
IMCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMCC vs. SCYX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMCC is a Hold and SCYX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (IMCC: $2.66 vs. SCYX: $0.84)
Brand notoriety: IMCC and SCYX are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: IMCC: 20% vs. SCYX: 57%
Market capitalization -- IMCC: $16.21M vs. SCYX: $32.77M
IMCC [@Pharmaceuticals: Generic] is valued at $16.21M. SCYX’s [@Pharmaceuticals: Generic] market capitalization is $32.77M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMCC’s FA Score shows that 0 FA rating(s) are green whileSCYX’s FA Score has 0 green FA rating(s).

  • IMCC’s FA Score: 0 green, 5 red.
  • SCYX’s FA Score: 0 green, 5 red.
According to our system of comparison, both IMCC and SCYX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMCC’s TA Score shows that 3 TA indicator(s) are bullish while SCYX’s TA Score has 6 bullish TA indicator(s).

  • IMCC’s TA Score: 3 bullish, 5 bearish.
  • SCYX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SCYX is a better buy in the short-term than IMCC.

Price Growth

IMCC (@Pharmaceuticals: Generic) experienced а -2.92% price change this week, while SCYX (@Pharmaceuticals: Generic) price change was -2.90% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Reported Earning Dates

SCYX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SCYX($32.8M) has a higher market cap than IMCC($16.2M). IMCC YTD gains are higher at: 14.109 vs. SCYX (-30.587). IMCC has higher annual earnings (EBITDA): -610K vs. SCYX (-26.67M). SCYX has more cash in the bank: 40.6M vs. IMCC (1.39M). SCYX has less debt than IMCC: SCYX (2.49M) vs IMCC (15.8M). IMCC has higher revenues than SCYX: IMCC (54.5M) vs SCYX (2.63M).
IMCCSCYXIMCC / SCYX
Capitalization16.2M32.8M49%
EBITDA-610K-26.67M2%
Gain YTD14.109-30.587-46%
P/E RatioN/A0.91-
Revenue54.5M2.63M2,072%
Total Cash1.39M40.6M3%
Total Debt15.8M2.49M635%
FUNDAMENTALS RATINGS
SCYX: Fundamental Ratings
SCYX
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
16

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMCCSCYX
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
IMCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TZUP9.950.38
+3.97%
Thumzup Media Corporation
WGS126.363.48
+2.83%
GeneDx Holdings Corp
TSCO60.490.80
+1.34%
Tractor Supply Co
ATHA0.40N/A
+0.65%
Athira Pharma
UXIN3.61-0.19
-4.87%
Uxin Limited

IMCC and

Correlation & Price change

A.I.dvisor tells us that IMCC and SCYX have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMCC and SCYX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMCC
1D Price
Change %
IMCC100%
N/A
SCYX - IMCC
24%
Poorly correlated
+4.78%
TLRY - IMCC
23%
Poorly correlated
-12.71%
CGC - IMCC
22%
Poorly correlated
-12.75%
CRON - IMCC
22%
Poorly correlated
-5.95%
OGI - IMCC
22%
Poorly correlated
-8.33%
More

SCYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCYX has been loosely correlated with AKAN. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if SCYX jumps, then AKAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCYX
1D Price
Change %
SCYX100%
+4.78%
AKAN - SCYX
35%
Loosely correlated
N/A
ELAN - SCYX
30%
Poorly correlated
-0.22%
AQST - SCYX
30%
Poorly correlated
N/A
CRON - SCYX
28%
Poorly correlated
-5.95%
CRDL - SCYX
26%
Poorly correlated
-2.24%
More